Article | Published:

RIP3 targets pyruvate dehydrogenase complex to increase aerobic respiration in TNF-induced necroptosis

Nature Cell Biologyvolume 20pages186197 (2018) | Download Citation


Receptor-interacting protein kinase 3 (RIP3)-regulated production of reactive oxygen species (ROS) positively feeds back on tumour necrosis factor (TNF)-induced necroptosis, a type of programmed necrosis. Glutamine catabolism is known to contribute to RIP3-mediated ROS induction, but the major contributor is unknown. Here, we show that RIP3 activates the pyruvate dehydrogenase complex (PDC, also known as PDH), the rate-limiting enzyme linking glycolysis to aerobic respiration, by directly phosphorylating the PDC E3 subunit (PDC-E3) on T135. Upon activation, PDC enhances aerobic respiration and subsequent mitochondrial ROS production. Unexpectedly, mixed-lineage kinase domain-like (MLKL) is also required for the induction of aerobic respiration, and we further show that it is required for RIP3 translocation to meet mitochondria-localized PDC. Our data uncover a regulation mechanism of PDC activity, show that PDC activation by RIP3 is most likely the major mechanism activated by TNF to increase aerobic respiration and its by-product ROS, and suggest that RIP3-dependent induction of aerobic respiration contributes to pathologies related to oxidative stress.

Access optionsAccess options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Additional information

Publisher’s note: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


  1. 1.

    Laster, S. M., Wood, J. G. & Gooding, L. R. Tumor necrosis factor can induce both apoptic and necrotic forms of cell lysis. J. Immunol. 141, 2629–2634 (1988).

  2. 2.

    Kerr, J. F., Wyllie, A. H. & Currie, A. R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26, 239–257 (1972).

  3. 3.

    Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332–336 (2009).

  4. 4.

    He, S. et al. Receptor interacting protein kinase-3 determines cellular necrotic response to TNF-α. Cell 137, 1100–1111 (2009).

  5. 5.

    Cho, Y. S. et al. Phosphorylation-driven assembly of the RIP1-RIP3 complex regulates programmed necrosis and virus-induced inflammation. Cell 137, 1112–1123 (2009).

  6. 6.

    Wu, X. N. et al. Distinct roles of RIP1-RIP3 hetero- and RIP3-RIP3 homo-interaction in mediating necroptosis. Cell. Death Differ. 21, 1709–1720 (2014).

  7. 7.

    Orozco, S. et al. RIPK1 both positively and negatively regulates RIPK3 oligomerization and necroptosis. Cell. Death Differ. 21, 1511–1521 (2014).

  8. 8.

    Chen, W. et al. Ppm1b negatively regulates necroptosis through dephosphorylating Rip3. Nat. Cell. Biol. 17, 434–444 (2015).

  9. 9.

    Sun, L. et al. Mixed lineage kinase domain-like protein mediates necrosis signaling downstream of RIP3 kinase. Cell 148, 213–227 (2012).

  10. 10.

    Zhao, J. et al. Mixed lineage kinase domain-like is a key receptor interacting protein 3 downstream component of TNF-induced necrosis. Proc. Natl. Acad. Sci. USA 109, 5322–5327 (2012).

  11. 11.

    Wang, H. et al. Mixed lineage kinase domain-like protein MLKL causes necrotic membrane disruption upon phosphorylation by RIP3. Mol. Cell. 54, 133–146 (2014).

  12. 12.

    Chen, X. et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell. Res. 24, 105–121 (2014).

  13. 13.

    Dondelinger, Y. et al. MLKL compromises plasma membrane integrity by binding to phosphatidylinositol phosphates. Cell. Rep. 7, 971–981 (2014).

  14. 14.

    Cai, Z. et al. Plasma membrane translocation of trimerized MLKL protein is required for TNF-induced necroptosis. Nat. Cell. Biol. 16, 55–65 (2014).

  15. 15.

    Goossens, V. et al. Redox regulation of TNF signaling. BioFactors 10, 145–156 (1999).

  16. 16.

    Schulze-Osthoff, K. et al. Cytotoxic activity of tumor necrosis factor is mediated by early damage of mitochondrial functions. Evidence for the involvement of mitochondrial radical generation. J. Biol. Chem. 267, 5317–5323 (1992).

  17. 17.

    Schulze-Osthoff, K., Beyaert, R., Vandevoorde, V., Haegeman, G. & Fiers, W. Depletion of the mitochondrial electron transport abrogates the cytotoxic and gene-inductive effects of TNF. EMBO J. 12, 3095–3104 (1993).

  18. 18.

    Tait, S. W. et al. Widespread mitochondrial depletion via mitophagy does not compromise necroptosis. Cell. Rep. 5, 878–885 (2013).

  19. 19.

    Schenk, B. & Fulda, S. Reactive oxygen species regulate Smac mimetic/TNFα-induced necroptotic signaling and cell death. Oncogene 34, 5796–5806 (2015).

  20. 20.

    Zhang, Y. et al. RIP1 autophosphorylation is promoted by mitochondrial ROS and is essential for RIP3 recruitment into necrosome. Nat. Commun. 8, 14329 (2017).

  21. 21.

    Kim, Y. S., Morgan, M. J., Choksi, S. & Liu, Z. G. TNF-induced activation of the Nox1 NADPH oxidase and its role in the induction of necrotic cell death. Mol. Cell. 26, 675–687 (2007).

  22. 22.

    Turrens, J. F., Freeman, B. A., Levitt, J. G. & Crapo, J. D. The effect of hyperoxia on superoxide production by lung submitochondrial particles. Arch. Biochem. Biophys. 217, 401–410 (1982).

  23. 23.

    Turrens, J. F. Mitochondrial formation of reactive oxygen species. J. Physiol. 552, 335–344 (2003).

  24. 24.

    Jastroch, M., Divakaruni, A. S., Mookerjee, S., Treberg, J. R. & Brand, M. D. Mitochondrial proton and electron leaks. Essays Biochem. 47, 53–67 (2010).

  25. 25.

    Harris, R. A., Bowker-Kinley, M. M., Huang, B. & Wu, P. Regulation of the activity of the pyruvate dehydrogenase complex. Adv. Enzym. Reg. 42, 249–259 (2002).

  26. 26.

    Roche, T. E. et al. Distinct regulatory properties of pyruvate dehydrogenase kinase and phosphatase isoforms. Prog. Nucleic Acid. Res. Mol. Biol. 70, 33–75 (2001).

  27. 27.

    Kaplon, J. et al. A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature 498, 109–112 (2013).

  28. 28.

    Hitosugi, T. et al. Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase kinase 1 is important for cancer metabolism. Mol. Cell. 44, 864–877 (2011).

  29. 29.

    Temkin, V., Huang, Q., Liu, H., Osada, H. & Pope, R. M. Inhibition of ADP/ATP exchange in receptor-interacting protein-mediated necrosis. Mol. Cell. Biol. 26, 2215–2225 (2006).

  30. 30.

    Hanson, G. T. et al. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J. Biol. Chem. 279, 13044–13053 (2004).

  31. 31.

    Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell. Biol. 183, 795–803 (2008).

  32. 32.

    Festjens, N. et al. Butylated hydroxyanisole is more than a reactive oxygen species scavenger. Cell. Death Differ. 13, 166–169 (2006).

  33. 33.

    Goossens, V., Grooten, J. & Fiers, W. The oxidative metabolism of glutamine. A modulator of reactive oxygen intermediate-mediated cytotoxicity of tumor necrosis factor in L929 fibrosarcoma cells. J. Biol. Chem. 271, 192–196 (1996).

  34. 34.

    Zachar, Z. et al. Non-redox-active lipoate derivates disrupt cancer cell mitochondrial metabolism and are potent anticancer agents in vivo. J. Mol. Med. 89, 1137–1148 (2011).

  35. 35.

    El Sayed, S. M. et al. Safety and outcome of treatment of metastatic melanoma using 3-bromopyruvate: a concise literature review and case study. Chin. J. Cancer 33, 356–364 (2014).

  36. 36.

    Deck, L. M. et al. Selective inhibitors of human lactate dehydrogenases and lactate dehydrogenase from the malarial parasite Plasmodium falciparum. J. Med. Chem. 41, 3879–3887 (1998).

  37. 37.

    Hiromasa, Y., Fujisawa, T., Aso, Y. & Roche, T. E. Organization of the cores of the mammalian pyruvate dehydrogenase complex formed by E2 and E2 plus the E3-binding protein and their capacities to bind the E1 and E3 components. J. Biol. Chem. 279, 6921–6933 (2004).

  38. 38.

    Schell, J. C. et al. A role for the mitochondrial pyruvate carrier as a repressor of the Warburg effect and colon cancer cell growth. Mol. Cell. 56, 400–413 (2014).

  39. 39.

    Thapa, R. J. et al. Interferon-induced RIP1/RIP3-mediated necrosis requires PKR and is licensed by FADD and caspases. Proc. Natl. Acad. Sci. USA 110, E3109–3118 (2013).

  40. 40.

    Zhong, C. Q. et al. Quantitative phosphoproteomic analysis of RIP3-dependent protein phosphorylation in the course of TNF-induced necroptosis. Proteomics 14, 713–724 (2014).

  41. 41.

    Grassian, A. R., Metallo, C. M., Coloff, J. L., Stephanopoulos, G. & Brugge, J. S. Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes. Dev. 25, 1716–1733 (2011).

  42. 42.

    Rodriguez, D. A. et al. Characterization of RIPK3-mediated phosphorylation of the activation loop of MLKL during necroptosis. Cell. Death Differ. 23, 76–88 (2016).

  43. 43.

    Boveris, A. & Chance, B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem. J. 134, 707–716 (1973).

  44. 44.

    Hennet, T., Richter, C. & Peterhans, E. Tumour necrosis factor-alpha induces superoxide anion generation in mitochondria of L929 cells. Biochem. J. 289, 587–592 (1993).

  45. 45.

    Joplin, R. et al. Subcellular localization of pyruvate dehydrogenase dihydrolipoamide acetyltransferase in human intrahepatic biliary epithelial cells. J. Pathol. 176, 381–390 (1995).

  46. 46.

    Turrens, J. F. & Boveris, A. Generation of superoxide anion by the NADH dehydrogenase of bovine heart mitochondria. Biochem. J. 191, 421–427 (1980).

  47. 47.

    Starkov, A. A. et al. Mitochondrial alpha-ketoglutarate dehydrogenase complex generates reactive oxygen species. J. Neurosci. 24, 7779–7788 (2004).

  48. 48.

    Nakagawa, T. et al. Cyclophilin D-dependent mitochondrial permeability transition regulates some necrotic but not apoptotic cell death. Nature 434, 652–658 (2005).

  49. 49.

    Linkermann, A. et al. Two independent pathways of regulated necrosis mediate ischemia–reperfusion injury. Proc. Natl. Acad. Sci. USA 110, 12024–12029 (2013).

  50. 50.

    Baines, C. P. et al. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434, 658–662 (2005).

  51. 51.

    Malatesha, G., Singh, N. K., Bharija, A., Rehani, B. & Goel, A. Comparison of arterial and venous pH, bicarbonate, PCO2 and PO2 in initial emergency department assessment. Emerg. Med. J. 24, 569–571 (2007).

  52. 52.

    Lin, J. et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell. Rep. 3, 200–210 (2013).

  53. 53.

    Kim, J. W., Tchernyshyov, I., Semenza, G. L. & Dang, C. V. HIF-1-mediated expression of pyruvate dehydrogenase kinase: a metabolic switch required for cellular adaptation to hypoxia. Cell. Metab. 3, 177–185 (2006).

  54. 54.

    Moriwaki, K., Bertin, J., Gough, P. J., Orlowski, G. M. & Chan, F. K. Differential roles of RIPK1 and RIPK3 in TNF-induced necroptosis and chemotherapeutic agent-induced cell death. Cell. Death Dis. 6, e1636 (2015).

  55. 55.

    Chen, X. et al. Translocation of mixed lineage kinase domain-like protein to plasma membrane leads to necrotic cell death. Cell. Res. 24, 105–121 (2014).

  56. 56.

    Zhang, D. W. et al. RIP3, an energy metabolism regulator that switches TNF-induced cell death from apoptosis to necrosis. Science 325, 332–336 (2009).

  57. 57.

    Lin, J. et al. A role of RIP3-mediated macrophage necrosis in atherosclerosis development. Cell. Rep. 3, 200–210 (2013).

  58. 58.

    Yoshida, S. et al. Molecular chaperone TRAP1 regulates a metabolic switch between mitochondrial respiration and aerobic glycolysis. Proc. Natl. Acad. Sci. USA 110, E1604–1612 (2013).

  59. 59.

    Hanson, G. T. et al. Investigating mitochondrial redox potential with redox-sensitive green fluorescent protein indicators. J. Biol. Chem. 279, 13044–13053 (2004).

  60. 60.

    Waypa, G. B. et al. Hypoxia triggers subcellular compartmental redox signaling in vascular smooth muscle cells. Circ. Res. 106, 526–535 (2010).

  61. 61.

    Cong, L. et al. Multiplex genome engineering using CRISPR/Cas systems. Science 339, 819–823 (2013).

  62. 62.

    Mali, P. et al. RNA-guided human genome engineering via Cas9. Science 339, 823–826 (2013).

  63. 63.

    Zhang, F. et al. Efficient construction of sequence-specific TAL effectors for modulating mammalian transcription. Nat. Biotechnol. 29, 149–153 (2011).

  64. 64.

    Frezza, C. et al. Haem oxygenase is synthetically lethal with the tumour suppressor fumarate hydratase. Nature 477, 225–228 (2011).

  65. 65.

    Wu, X. et al. Investigation of receptor interacting protein (RIP3)-dependent protein phosphorylation by quantitative phosphoproteomics. Mol. Cell. Proteom. 11, 1640–1651 (2012).

  66. 66.

    Dempsey, G. T., Vaughan, J. C., Chen, K. H., Bates, M. & Zhuang, X. Evaluation of fluorophores for optimal performance in localization-based super-resolution imaging. Nat. Methods 8, 1027–1036 (2011).

  67. 67.

    French, J. B. et al. Spatial colocalization and functional link of purinosomes with mitochondria. Science 351, 733–737 (2016).

  68. 68.

    Narendra, D., Tanaka, A., Suen, D. F. & Youle, R. J. Parkin is recruited selectively to impaired mitochondria and promotes their autophagy. J. Cell. Biol. 183, 795–803 (2008).

  69. 69.

    Wieckowski, M. R., Giorgi, C., Lebiedzinska, M., Duszynski, J. & Pinton, P. Isolation of mitochondria-associated membranes and mitochondria from animal tissues and cells. Nat. Protoc. 4, 1582–1590 (2009).

Download references


This work was supported by the National Natural Science Foundation of China (91429301), the National Basic Research Program of China (973 Program; 2015CB553800 and 2014CB541804), the National Natural Science Foundation of China (31420103910, 31330047 and 81788104), the 111 Project (B12001), the National Science Foundation of China for Fostering Talents in Basic Research (J1310027) and the Open Research Fund of State Key Laboratory of Cellular Stress Biology, Xiamen University.

Author information


  1. State Key Laboratory of Cellular Stress Biology, Innovation Center for Cell Signaling Network, School of Life Sciences, Xiamen University, Xiamen, Fujian, China

    • Zhentao Yang
    • , Yan Wang
    • , Yingying Zhang
    • , Chuan-Qi Zhong
    • , Hengxiao Ni
    • , Xin Chen
    • , Yaoji Liang
    • , Jianfeng Wu
    • , Dawang Zhou
    •  & Jiahuai Han
  2. State Key Laboratory of Genetic Engineering, School of Life Science and Institute of Biomedical Sciences, The Obstetrics & Gynecology Hospital of Fudan University, Shanghai, China

    • Xiadi He
    •  & Shimin Zhao


  1. Search for Zhentao Yang in:

  2. Search for Yan Wang in:

  3. Search for Yingying Zhang in:

  4. Search for Xiadi He in:

  5. Search for Chuan-Qi Zhong in:

  6. Search for Hengxiao Ni in:

  7. Search for Xin Chen in:

  8. Search for Yaoji Liang in:

  9. Search for Jianfeng Wu in:

  10. Search for Shimin Zhao in:

  11. Search for Dawang Zhou in:

  12. Search for Jiahuai Han in:


Z.Y. and J.H. conceived and designed the experiments. Z.Y., Y.W., Y.Z. and X.C. performed the experiments. X.H. and C.-Q.Z. performed the GC-MS and MS experiments and analysed the obtained results. H.N., Y.L. and J.W. helped to prepare cell lines for the study. S.Z. and D.Z. provided technical support. Z.Y. and J.H. interpreted the data and wrote the paper.

Competing interests

The authors declare no competing financial interests.

Corresponding author

Correspondence to Jiahuai Han.

Supplementary information

  1. Supplementary Information

    Supplementary Figures, Legends, Table Legends.

  2. Life Sciences Reporting Summary

  3. Supplementary Table 1

    Statistics source data.

About this article

Publication history





Further reading